Quick Answer
CHINA PHARMA HOLDINGS, INC. reported Stockholders Equity of $7.75 million for the year ending 2024.
- CHINA PHARMA HOLDINGS, INC. showed an increase of +3.9% in Stockholders Equity from 2023 to 2024.
- This data is from CHINA PHARMA HOLDINGS, INC.'s annual report (Form 10-K), filed with the SEC on March 31, 2025.
- XBRL data for this metric is available from 2009 to 2024 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2012: $148.52 million | Q1 2013: $146.52 million | Q2 2013: $144.28 million | Q3 2013: $142.86 million | Q1 2014: $129.44 million | Q2 2014: $120.95 million | Q3 2014: $114.66 million | Q1 2015: $98.77 million | Q2 2015: $95.00 million | Q3 2015: $86.81 million | Q1 2016: $71.57 million | Q2 2016: $66.96 million | Q3 2016: $64.94 million | Q1 2017: $58.42 million | Q2 2017: $57.14 million | Q3 2017: $57.03 million | Q1 2018: $44.45 million | Q2 2018: $41.03 million | Q3 2018: $37.63 million | Q1 2019: $30.62 million | Q2 2019: $28.97 million | Q3 2019: $27.36 million | Q1 2020: $8.38 million | Q2 2020: $8.40 million | Q3 2020: $7.86 million | Q1 2021: $7.17 million | Q2 2021: $6.52 million | Q3 2021: $6.85 million | Q1 2022: $5.34 million | Q2 2022: $4.02 million | Q3 2022: $2.83 million | Q1 2023: $4.67 million | Q2 2023: $4.35 million | Q3 2023: $6.11 million | Q4 2023: $7.45 million | Q1 2024: $8.29 million | Q2 2024: $7.41 million | Q3 2024: $6.53 million | Q4 2024: $7.75 million | Q1 2025: $6.97 million | Q2 2025: $6.46 million | Q3 2025: $8.31 million.
- Over the full 16 years of available data (2009 to 2024), CHINA PHARMA HOLDINGS, INC.'s Stockholders Equity has declined by 91.2%.
- Historical annual values: Fiscal year 2024: $7.75 million | Fiscal year 2023: $7.45 million | Fiscal year 2022: $4.29 million | Fiscal year 2021: $6.02 million | Fiscal year 2020: $8.00 million | Fiscal year 2019: $9.24 million | Fiscal year 2018: $30.20 million | Fiscal year 2017: $43.07 million | Fiscal year 2016: $58.91 million | Fiscal year 2015: $72.64 million | Fiscal year 2014: $92.74 million | Fiscal year 2013: $132.94 million | Fiscal year 2012: $148.52 million | Fiscal year 2011: $142.48 million | Fiscal year 2010: $117.94 million | Fiscal year 2009: $87.87 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: